HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fetal pulmonary maturity: relationship between optical density (650 nm) to the lecithin/sphingomyelin ratio and phosphatidylglycerol in amniotic fluid.

Abstract
An optical density value greater than or equal to 0.15 at A650 n m of amniotic fluid obtained through transabdominal amniocentesis from a high risk obstetrical population, which excluded diabetes mellitus, isoimmunization, and amniotic fluid infection, correlated 98.6% with a mature lecithin to sphingomyelin ratio (L/S) greater than or equal to 2.0% and 41.6% with the presence of phosphatidylglycerol (PG). The corresponding false positive rates were 1.4% and 16.8%, respectively. In 30 infants delivered within 48 h of testing, A650 n m greater than or equal to 0.15 correlated 100% with absence of respiratory distress syndrome. A650 n m is not recommended for Rhesus immunized gestations, diabetic pregnancies and amniotic fluid infection due to a high false positive rate with A650 nm compared to L/S and PG.
AuthorsS Moodley, J H Liu, R C Cherkis, R K Miller, T A Merrit, L E Whalen
JournalInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (Int J Gynaecol Obstet) Vol. 21 Issue 3 Pg. 199-203 (Jun 1983) ISSN: 0020-7292 [Print] United States
PMID6139307 (Publication Type: Journal Article)
Chemical References
  • Phosphatidylcholines
  • Phosphatidylglycerols
  • Sphingomyelins
Topics
  • Amniotic Fluid (analysis, physiology)
  • Female
  • Fetal Membranes, Premature Rupture (physiopathology)
  • Fetal Organ Maturity
  • Humans
  • Infant, Newborn
  • Lung (embryology)
  • Phosphatidylcholines (analysis)
  • Phosphatidylglycerols (analysis)
  • Pregnancy
  • Respiratory Distress Syndrome, Newborn (diagnosis)
  • Retrospective Studies
  • Sphingomyelins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: